canada clinical guidance

Coeliac disease (testing + referral)

A Canadian clinical summary of coeliac disease (testing + referral), with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Alberta is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient鈥檚 province or territory.

Alberta source: bounded use

Provincial Celiac Disease Primary Care Pathway supplies a Canadian implementation example for this summary. It must not be presented as the rule outside Alberta.
sources for this section:AHS celiac pathway

Source-attributed clinical priorities

  • Test with appropriate serology while the patient is eating gluten and measure total immunoglobulin A or use an alternative assay when needed.
  • Confirm the diagnosis through the Canadian gastroenterology pathway before recommending a lifelong gluten-free diet.
  • Assess nutritional deficiency, bone health and associated autoimmune disease and arrange dietitian-supported follow-up.
  • Do not start a gluten-free diet before diagnostic testing because serology and histology may normalize.
sources for this section:AHS celiac pathway

Practical assessment and management workflow

1
Record diarrhea, weight, anemia, bone, neurologic, dermatitis and family or autoimmune history.
2
Order tissue-transglutaminase IgA with total IgA while the patient consumes gluten.
3
Use alternate serology for IgA deficiency and refer for confirmatory gastroenterology assessment.
4
After diagnosis, involve a dietitian and monitor symptoms, serology, deficiencies and bone health.
sources for this section:AHS celiac pathway

Safety, red flags and urgent escalation

  • Severe malnutrition, dehydration or major electrolyte disturbance needs urgent management.
  • Persistent symptoms despite adherence require review for ongoing gluten exposure, refractory disease or another diagnosis.
  • Screen first-degree relatives and associated autoimmune disease according to the Canadian pathway.
sources for this section:AHS celiac pathway

Confirm the local pathway before acting

Alberta is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient鈥檚 province or territory.
sources for this section:AHS celiac pathway

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:AHS celiac pathway

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Alberta Health ServicesProvincial Celiac Disease Primary Care Pathwayaccessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.